Cargando…

Models for Predicting Response to Immunotherapy and Prognosis in Patients with Gastric Cancer: DNA Damage Response Genes

OBJECTIVE: DNA damage response (DDR) is a complex system that maintains genetic integrity and the stable replication and transmission of genetic material. m6A modifies DDR-related gene expression and affects the balance of DNA damage response in tumor cells. In this study, a risk model based on m6A-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Rui, Chen, Shuran, Lu, Fei, Zheng, Ni, Peng, Guisen, Li, Yan, Yang, Pan, Wen, Hexin, Qiu, Quanwei, Wang, Yitong, Wu, Huazhang, Liu, Mulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792237/ https://www.ncbi.nlm.nih.gov/pubmed/36578802 http://dx.doi.org/10.1155/2022/4909544

Ejemplares similares

m(7)G-Related DNA Damage Repair Genes are Potential Biomarkers for Predicting Prognosis and Immunotherapy Effectiveness in Colon Cancer Patients
por: Chen, Shuran, et al.
Publicado: (2022)

Identification and Validation of METTL3-Related Molecules for Predicting Prognosis and Efficacy of Immunotherapy in Gastric Cancer Based on m6A Methylome and Transcriptome Sequencing Analysis
por: Chen, Shuran, et al.
Publicado: (2022)

Integrative proteomics and m6A microarray analyses of the signatures induced by METTL3 reveals prognostically significant in gastric cancer by affecting cellular metabolism
por: Peng, Guisen, et al.
Publicado: (2022)

GPC1 promotes the growth and migration of colorectal cancer cells through regulating the TGF-β1/SMAD2 signaling pathway
por: Lu, Fei, et al.
Publicado: (2022)

The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer
por: Zhao, Zidan, et al.
Publicado: (2023)

Comprehensive analysis of competitive endogenous RNAs network reveals potential prognostic lncRNAs in gastric cancer
por: Sun, Dengzhong, et al.
Publicado: (2020)

The DNA damage response in immunotherapy and radiation
por: Samstein, Robert M., et al.
Publicado: (2018)

The role of multiple metabolic genes in predicting the overall survival of colorectal cancer: A study based on TCGA and GEO databases
por: Shi, Weijun, et al.
Publicado: (2021)

Interplay between the DNA Damage Response and Immunotherapy Response in Cancer
por: Lee, Elizabeth Chun Yong, et al.
Publicado: (2022)

A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma
por: Peng, Linjie, et al.
Publicado: (2022)

DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma
por: Chen, Yunfei, et al.
Publicado: (2021)

Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy
por: Czajkowski, Daniel, et al.
Publicado: (2022)

Interfaces between cellular responses to DNA damage and cancer immunotherapy
por: Pilger, Domenic, et al.
Publicado: (2021)

Identification and validation of a T cell marker gene-based signature to predict prognosis and immunotherapy response in gastric cancer
por: Zhong, Jinlin, et al.
Publicado: (2023)

A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer
por: Liu, Shi-jin, et al.
Publicado: (2021)

Identify a DNA Damage Repair Gene Signature for Predicting Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinoma
por: Zhou, Hong, et al.
Publicado: (2022)

DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer
por: Shang, Zhen, et al.
Publicado: (2023)

Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy
por: Ye, Zu, et al.
Publicado: (2021)

Cell differentiation trajectory predicts patient potential immunotherapy response and prognosis in gastric cancer
por: Xiang, Renshen, et al.
Publicado: (2021)

Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer
por: Song, Junquan, et al.
Publicado: (2022)

Aging-related features predict prognosis and immunotherapy efficacy in hepatocellular carcinoma
por: Hong, Ting, et al.
Publicado: (2022)

Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy
por: Jiang, Minlin, et al.
Publicado: (2021)

DNA Damage Response Evaluation Provides Novel Insights for Personalized Immunotherapy in Glioma
por: Chen, Mu, et al.
Publicado: (2022)

Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer
por: Cao, Rui, et al.
Publicado: (2021)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer
por: Song, Junquan, et al.
Publicado: (2022)

Immune activity score to assess the prognosis, immunotherapy and chemotherapy response in gastric cancer and experimental validation
por: Wu, Xuan, et al.
Publicado: (2023)

Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma
por: Puglisi, Rossella, et al.
Publicado: (2021)

DNA Damage Response
por: Oksenych, Valentyn, et al.
Publicado: (2021)

Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer
por: Hui, Pengyu, et al.
Publicado: (2023)

DNA Damage Response Genes in Osteosarcoma
por: Tang, Ying, et al.
Publicado: (2021)

PAICS contributes to gastric carcinogenesis and participates in DNA damage response by interacting with histone deacetylase 1/2
por: Huang, Nan, et al.
Publicado: (2020)

NF-κB-Related Metabolic Gene Signature Predicts the Prognosis and Immunotherapy Response in Gastric Cancer
por: Chen, Qiuxiang, et al.
Publicado: (2022)

A SERPINE1-Based Immune Gene Signature Predicts Prognosis and Immunotherapy Response in Gastric Cancer
por: Xu, Xiang, et al.
Publicado: (2022)

Tumor immune response and immunotherapy in gastric cancer
por: Kwak, Yoonjin, et al.
Publicado: (2020)

Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma
por: Shang, Taiyu, et al.
Publicado: (2023)

Expression of DNA Damage Response Markers in Early-Onset or Familial Gastric Cancers
por: Kim, Hee Sung, et al.
Publicado: (2019)

JMJD6 modulates DNA damage response through downregulating H4K16ac independently of its enzymatic activity
por: Huo, Dawei, et al.
Publicado: (2019)

DNA Repair and Replication-Related Gene Signature Based on Tumor Mutation Burden Reveals Prognostic and Immunotherapy Response in Gastric Cancer
por: Zhang, Lei, et al.
Publicado: (2022)

Comprehensive Molecular Analyses of Notch Pathway-Related Genes to Predict Prognosis and Immunotherapy Response in Patients with Gastric Cancer
por: Song, Yinsen, et al.
Publicado: (2023)

Identification of a novel MSI-related ceRNA network for predicting the prognosis and immunotherapy response of gastric cancer
por: Zhang, Lei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5ea428hmeo7l9391emurgh6hhn